MINAPHARM Pharmaceuticals Revenue

In the year 2024, MINAPHARM Pharmaceuticals had annual revenue of 5.66B EGP with 45.55% growth. MINAPHARM Pharmaceuticals had revenue of 2.08B in the quarter ending December 31, 2024, with 147.41% growth.

Revenue

5.66B

Revenue Growth

+45.55%

P/S Ratio

0.48

Revenue / Employee

12.59M

Employees

450

Market Cap

2.73B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.66B	1.77B	45.55%
Dec 31, 2023	3.89B	271.51M	7.50%
Dec 31, 2022	3.62B	615.19M	20.47%
Dec 31, 2021	3.01B	644.34M	27.29%
Dec 31, 2020	2.36B	309.95M	15.11%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Commercial International Bank Egypt (CIB) S.A.E.	107.76B
El Sewedy Electric Company	246.12B
Talaat Moustafa Group Holding	45.30B
Eastern Company S.A.E	34.08B
Misr Fertilizer Production Company	21.20B
Egypt Aluminum	42.42B
Alexandria Container&Cargo Handling Company	8.41B
Telecom Egypt Company	89.35B

Revenue Rankings